Skip to content

Point of Care, High Resolution and 3-Dimensional Ultrasonography

Point of Care, High Resolution and 3-Dimensional Ultrasonography for Diagnosing Peri-Implant Bone Loss

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05282212
Enrollment
41
Registered
2022-03-16
Start date
2022-03-09
Completion date
2023-08-31
Last updated
2023-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Loss in Jaw, Dental Diseases

Brief summary

The overall purpose of this study is to establish an ultrasound technique to aid in oral and dental examination of soft and hard tissues. Ultrasound is currently not used in Dentistry and associated oral examinations and we are exploring its usefulness for clinical practice. This study will investigate the use of ultrasonic imaging for planning and placing dental implants, as well as evaluate the use of ultrasonic imaging for monitoring marginal bone loss around dental implants.

Interventions

DIAGNOSTIC_TESTUltrasound Scan

Within 90 days before the revision surgery, a calibrated examiner will ultrasonically scan the implants. The ultrasound device has been validated for its usability and design on human subjects in our recent clinical study (the University of Michigan Institutional Review Board under the number HUM00139630 and was registered with the National Institutes of Health U.S. National Library of Medicine database for clinical trials (clinicaltrials.gov) under the following identifier: NCT03558282) Coupling will be achieved with commercially available sterilized US gel (Sterile Aquasonic, Fairfield, NJ). The US probe will be mounted on an adjustable arm attached to a fixed stand. The probe is navigated by a calibrated examiner at the implant of interest and then will execute a total ±5 mm linear mesio-distal and coronal-apical translations to create 3D cross-sectional and transverse volumes, respectively and stored as an imageframe series, i.e., a DICOM format cineloop.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 years or older * • Have a dental implant infection (bleeding on probing/exudate and probing depths of at least 5 mm) and are or will be scheduled for revision surgery within 90 days of the screening visit. * Willing to comply with all study procedures and be available for the duration of the study.

Exclusion criteria

* Unwilling or unable to read and sign informed consent form. * Pregnancy or unsure of their pregnancy status (self-reported)

Design outcomes

Primary

MeasureTime frameDescription
Dental Implant bone levelWithin 90 days before dental surgeryThe difference between ultrasound-determined measurements and intraoperative measurements (optical scanner images as indirect measurements)
Dental implant radicular bone thicknessWithin 90 days before dental surgeryThe difference between ultrasound-determined measurements and intraoperative measurements (optical scanner images as indirect measurements)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026